Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 33.20180.22-67.21-38.59-

What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?

The latest EBIT Growth ratio of PIRAMAL PHARMA is 33.20 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202533.20
Mar2024180.22
Mar2023-67.21
Mar2022-38.59
Mar2021-

How is EBIT Growth of PIRAMAL PHARMA Trending?

Years EBIT Growth % Change
Mar2025 33.2
-81.58
Mar2024 180.22
Positive
Mar2023 -67.21
Negative
Mar2022 -38.59
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EBIT Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,822.4 Cr -0.8% -11.4% -32.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,220.0 Cr 1.2% 2.3% -1.1% Stock Analytics
DIVIS LABORATORIES ₹168,486.0 Cr 0.9% -2.5% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,963.0 Cr 0.5% -1.5% 12.3% Stock Analytics
CIPLA ₹121,751.0 Cr 1.1% -1.6% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,866.0 Cr 2.7% 2.9% 3.3% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0.8%

-11.4%

-32.4%

SENSEX

0.1%

0.9%

4.5%


You may also like the below Video Courses